NCT03492424Recruiting
Ablative Therapy in the Management of Prostate Cancer
Source: ClinicalTrials.gov · Last updated 23 Dec 2025
Brief summary (registry, in English)
The purpose of this study is collect observational data regarding patterns of care and outcomes of focal therapies for prostate cancer, including but not limited to: high-intensity focused ultrasound (HIFU), cryotherapy, focal laser ablation, irreversible electroporation, photodynamic therapy, and brachytherapy.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 30 Mar 2018
- Start date
- 2 Jan 2018
- Primary completion date
- 2 Mar 2032
- Lead sponsor
- Weill Medical College of Cornell University
- Diseases
- Prostate cancer
- NCT number
- NCT03492424
What you commit to
- Study type: Observational
- Planned participants: 200
- From 2 Jan 2018 to the primary completion date, 2 Mar 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinically-evident metastatic disease
Other
- Unable to fill out an English-language questionnaire
Who the study is looking for
- \>18 years of age
- Undergoing focal therapy for primary or salvage treatment of prostate cancer, or
- Have received prior focal therapy
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Weill Cornell Medicine Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.